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Transcriptomic analysis of mouse liver
reveals a potential hepato-enteric
pathogenic mechanism in acute
Toxoplasma gondii infection
Jun-Jun He1, Jun Ma1,3, Hany M. Elsheikha2, Hui-Qun Song1, Si-Yang Huang1,4* and Xing-Quan Zhu1,4*
Abstract
Background: Toxoplasma gondii is a worldwide spread pathogen which can infect all tissues of its host. The
transcriptomic responses of infected brain and spleen have been reported. However, our knowledge of the
global transcriptomic change in infected liver is limited. Additionally, T. gondii infection represents a highly
dynamic process involving complex biological responses of the host at many levels. Herein, we describe such
processes at a global level by discovering gene expression changes in mouse livers after acute infection with
T. gondii ToxoDB#9 strain.
Results: Global transcriptomic analysis identified 2,758 differentially expressed transcripts in infected liver, of
which 1,356 were significantly downregulated and 1,402 upregulated. GO and KEGG database analyses showed
that host immune responses were upregulated, while the metabolic-related processes/pathways were downregulated,
especially xenobiotic metabolism, fatty acid metabolism, energy metabolism, and bile biosynthesis and secretion. The
metabolism of more than 800 chemical compounds including anti-Toxoplasma prescribed medicines were predicted to
be modulated during acute T. gondii infection due to the downregulation of enzymes involved in xenobiotic metabolism.
Conclusions: To the best of our knowledge, this is the first global transcriptomic analysis of mouse liver infected
by T. gondii. The present data indicate that during the early stage of liver infection, T. gondii can induce changes
in liver xenobiotic metabolism, upregulating inflammatory response and downregulating hepatocellular PPAR
signaling pathway, altering host bile biosynthesis and secretion pathway; these changes could enhance host
intestinal dysbacteriosis and thus contribute to the pathological changes of both liver and intestine of infected
mice. These findings describe the biological changes in infected liver, providing a potential mechanistic pathway
that links hepatic and intestinal pathologies to T. gondii infection.
Keywords: Toxoplasma gondii, Mouse liver, Transcriptome, RNA-seq, Liver function
Background
Toxoplasmosis, caused by the intracellular protozoan
parasite Toxoplasma gondii, is a worldwide infectious dis-
ease that has the capacity to affect any warm-blooded ver-
tebrate. To date, over 180T. gondii genotypes have been
identified. In North America and Europe, the widespread
genotypes of T. gondii are the types I, II and III [1, 2].
ToxoDB#9, also known as genotype Chinese 1, is the pre-
dominant genotype in China [3, 4]. The wide host range,
high prevalence and distinct clinical diversity of parasite
genotypes represent a significant public health risk.
Although T. gondii exhibits striking neurotropic and
ocular affinities, this parasite can also infect visceral or-
gans, such as liver, spleen, pancreas, heart and lymph
nodes. Hepatic toxoplasmosis does exist, but probably
because T. gondii spreads to the liver during the acute
phase of infection, this may go unnoticed. Indeed,
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several hepatic pathologies, such as hepatomegaly,
hepatitis, granuloma, necrosis, cholestatic jaundice and
cirrhosis have been linked to T. gondii infection [5–8].
Toxoplasma gondii infection has also been incriminated
in causing abnormal liver function tests [9] and liver
dysfunction in liver and kidney transplant recipients
[10]. Acute T. gondii infection with RH strain in mice
revealed an association between the increased number
of hepatic stellate cells (HSCs) and the amount of T.
gondii antigens, suggesting a regulatory role for HSCs
in the pathogenesis of T. gondii-induced hepatitis [11].
Liver plays an important role in many biochemical and
physiological processes, such as detoxification of xenobi-
otics or drugs and producing bile, which has a regulatory
role in nutrition absorption, food digestion, maintaining
gut bacterial balance and immune response [12]. On the
other hand, some T. gondii strains have evolved to sub-
vert host immune response [13]. For example, rhoptry
protein 16 (ROP16) of Type I T. gondii can manipulate
the production of host interleukin (IL)-12 and influence
host IFN-γ production [14]. Thus, it is reasonable to
hypothesize that T. gondii induces alteration in immune-
regulatory and other genes in the hepatic tissues to
evade host immune defense mechanisms during the
early course of infection. Studying the global gene ex-
pression in liver of mice during acute T. gondii infection
may uncover new facets of the immune-regulatory
mechanisms that govern the interaction between T. gon-
dii and the host.
Transcriptome analysis has been a powerful tool for
the study of global biological changes in various body
organs of mice infected with T. gondii. For example,
Tanaka et al. applied RNA-seq to analyze global tran-
scriptomic changes in mice brain infected with T. gon-
dii [15]. Knight et al. used transcriptomics to elucidate
the role of inflammation in T. gondii-inducing retino-
choroiditis [16]. We previously analyzed the transcrip-
tomic changes of infected mouse spleen to unravel the
immune response to T. gondii infection [17]. However,
despite the importance of the liver in the metabolism
and other functions in the human body, the global tran-
scriptomic changes of liver are still unknown. To better
understand the molecular mechanisms that mediate the
interaction between T. gondii infection and the liver, we
used next-generation sequencing to assess the global
transcriptomic gene expression in the liver of experimen-
tally infected mice during the early course of infection.
Our results revealed global gene expression changes,
which are important in elucidating mechanisms linking
liver and intestinal pathologies during early T. gondii
infection. Full and complete understanding of these
mechanisms will provide information likely to be crit-
ical for the development of rationally designed thera-
peutics or vaccines to mitigate this infection.
Methods
Animals, parasite challenge and sample collection
The PYS strain of T. gondii (genotype ToxoDB#9) is
preserved and passaged in HFF cells in our laboratory.
Six-week-old female BALB/c mice of special pathogen
free (SPF) were purchased from Laboratory Animal
Center of Lanzhou Veterinary Research Institute, Chinese
Academy of Agriculture Science. Six mice were randomly
divided into two groups (three replicates per group). Each
mouse of the infected group was peritoneally infected with
200 tachyzoites of the PYS strain, while control mice were
mock-injected with phosphate buffer saline (PBS). Mice
were provided non-medicated feed and water ad libitum
throughout the experiment. Six days post-infection (dpi)
mice were humanely sacrificed by CO2 asphyxiation
and liver tissues collected and stored at -80 °C until
use. Toxoplasma gondii infection was confirmed by
polymerase chain reaction (PCR) as described previ-
ously [18]. All mice were handled strictly in accordance
with the Animal Ethics Procedures and Guidelines of
the People’s Republic of China.
Histopathological analysis and liver functional analysis
For histopathological analysis and liver functional
analysis, twelve BALB/c mice were randomly divided
into two groups (six replicates per group). Each
mouse in the infected group was peritoneally in-
fected with 200 tachyzoites of the PYS strain, while
mice of the control group were mock-injected with
PBS. All mice were humanely sacrificed by CO2 as-
phyxiation and the sera, livers were collected at six
dpi. The collected livers were fixed in 10 % neutral
buffered formalin solution for 1 week, paraffin-
embedded and stained with haematoxylin and eosin.
Toxoplasma gondii infection in liver was confirmed
by PCR as described previously [18]. Serum albumin,
globulin, adenosine deaminase activity, alkaline phos-
phatase activity, total bilirubin, total bile acid, high
density lipoprotein, low density lipoprotein, cholin-
esterase activity, glutamic-pyruvic transaminase activ-
ity and glutamic-oxaloacetic transaminase activity
were measured with the assistance of the No. 2 Peo-
ple’s Hospital of Lanzhou. Statistical analysis was
performed by using SPSS Version 13.0 (SPSS Inc.,
Chicago, IL, USA). One sample Kolmogorov-Smirnov
test was applied to test whether data exhibit normal distri-
bution. Independent sample t-test was applied to analyze
whether the variables mentioned above were signifi-
cantly different between mice from infected versus con-
trol group. The data that did not follow a normal
distribution were analyzed with Mann-Whitney test
with Dunn’s multiple comparison post-hoc test; P < 0.05
was taken as significance cut-off.
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RNA extraction, sequencing and identification of
differentially expressed transcripts (DETs)
Total RNA was prepared individually from the cryopre-
served mice liver samples using TRIzol Reagent accord-
ing to the manufacturer’s protocol (Invitrogen China
Ltd, Beijing, China). All extracted RNA samples were
treated with 20 units of RNase-Free DNase (Ambion,
Shanghai, China) to remove residual genomic DNA
according to the manufacturer’s recommendations. The
integrity and quantity of all RNA samples were confirmed
by Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA, USA) and Nanodrop 2000 (Thermo Scientific,
Wilmington, DE, USA), respectively. Five micrograms RNA
of each sample was individually used for the construc-
tions of transcriptome libraries using IlluminaTruSeq™
RNA Sample Preparation Kit (Illumina, San Diego, CA,
USA) and sequenced by using IlluminaHiSeq™2000 ac-
cording to the manufacturer’s instructions. Q20 was
used as quality control standard to filter raw reads.
After filtering the low quality reads, the adaptors of
high quality reads were removed and then clean reads
were aligned to the mouse genome (mm10) using
SOAP aligner/SOAP2 and GTF annotation data file
(Mus_musculus.GRCm38.69). No more than five mis-
matches were allowed in the alignment. The gene ex-
pression level was calculated using RPKM method [19].
Differentially expressed transcript of each biological
replicate was identified by using two-fold change (log2
fold-change ≥ 1 or ≤ -1), statistical test referring to the
significance of digital gene expression profiles [20], and
a 0.001 Benjamini & Hochberg False Discovery Rate
(FDR) [21] corrected P-value cut-off for the thresholds.
Only the transcript that was upregulated or downregu-
lated in three biological replicates was identified as dif-
ferentially expressed transcript (DETs). RNA isolation,
library construction, RNA-sequencing (RNA-seq), reads
alignment and DETs identification were performed at
BGI-Shenzhen, China.
Validation of RNA-seq results by quantitative real-time
PCR (Q-PCR)
Gene expression data was further verified by Q-PCR.
All six RNA templates that were used for RNA-seq
were reverse transcribed to cDNA using M-MLV re-
verse transcriptase (Promega, Beijing, China) according
to the manufacturer’s instructions, individually. β-actin
was chosen as endogenous reference gene and ten genes
were randomly selected for validation using Q-PCR. All
Q-PCR reactions were performed on the Rotor-Gene Q
(QIAGEN, Hilden, Germany) using SYBR Green GoTaq®
qPCR Master Mix (Promega, Beijing, China) according to
the manufacturer’s instructions. The selected genes were
analyzed in triplicates and the primers used in this study
are shown in Table 1. The Q-PCR cycle conditions were
as follows: 95 °C for 5 min followed by 40 cycles of 95 °C
for 10 s, 60 °C for 10 s, 72 °C for 20 s; melt curve analysis
ranged from 72 °C to 95 °C to ensure that specific product
was amplified in each reaction. The 2−ΔΔCTrelative ex-
pression calculating method was used to calculate gene
expression [22].
Bioinformatics analysis of differentially expressed genes
Gene Ontology (GO) analysis of DETs was performed
on the cytoscape plugin, BiNGO [23]. All data files used
in BiNGO were downloaded from Gene Ontology data-
base (http://www.geneontology.org/) [24]. Pathway ana-
lysis of DETs was performed through KEGG database
(KEGG, http://www.genome.jp/kegg/) [25]. Hypergeo-
metric tests and Benjamini & Hocherg False Discovery
Rate (FDR) correction were performed to identify signifi-
cantly enriched GO terms or KEGG pathways. The cor-
rected P < 0.05 was used as a cut-off for the thresholds.
Differently expressed GO terms or KEGG pathways were
also identified where the FDR corrected P-value was less
than 0.05, the number of DEPs was greater than 3, and
the ratio between upregulated protein and downregu-
lated protein was greater than 2 or less than 0.5. Com-
parative Toxicogenomics Database (http://ctdbase.org/)
[26] was used for analysis of the relationship among
xenobiotic metabolism, liver disease and DETs. Tran-
scription factor analysis of DETs was carried out through
Pscan web service (http://159.149.160.51/pscan/) [27]. In
the Pscan web service, Mus musculus was selected in or-
ganism option and -950 + 50 region of transcriptional start
site (TSS) was selected for transcription factor prediction.
Results
Confirmation of T. gondii infection in mice
All mice of the infected group exhibited signs indicative of
toxoplasmosis, while mice in the control group remained
normal, without any clinical changes. No mouse has died
at 6 days post-infection. The results of PCR detection and
DNA sequencing indicated that all livers of infected mice
were positive for B1 gene of T. gondii, while those in the
control group were PCR negative.
RNA examination, transcriptomic features of mice liver
and quantitative real-time PCR validation
The RNA integrity number (RIN) of all six RNA tem-
plates used for RNA-seq was > 7. Over 47,000,000 clean
reads were obtained in each mouse. The RNA-seq raw
data are available at NCBI (accession no: PRJNA308347).
More than 18,000 transcripts were identified. Coeffi-
cients of variation (CV) of the three biological replicates
are shown in Fig. 1a. A total of 2,758 transcripts were
identified as differentially expressed in the present study,
including 1,356 downregulated transcripts and 1,402 up-
regulated transcripts. The details of the differentially
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expressed transcripts are shown in Additional file 1:
Table S1. Results of ten randomly selected genes for
Q-PCR validation are shown in Fig. 1b. No significant
difference was found between results of the Q-PCR
and RNA-seq. GO and KEGG enrichment analysis
were applied to study the global biological change in
infected liver. Our data indicate that 1,218 biological
processes (Additional file 2: Table S2), 259 molecular
functions (Additional file 3: Table S3), and 96 cellular
components (Additional file 4: Table S4) were differ-
entially expressed. Most upregulated GO terms were
immune response related, while most downregulated
GO terms were metabolic related, such as amino acid
metabolic, xenobiotic metabolic, sterol metabolic, fatty
acid metabolic, lipid metabolic and energy metabolic
related GO terms. The differentially expressed en-
zymes involved in xenobiotic or drug metabolism are
shown in Fig. 2. Consistent with GO enrichment ana-
lysis, all enriched pathways which involved in infection
and immune response were upregulated, while the me-
tabolism related pathways were downregulated in in-
fected livers (Fig. 3). For example, both the upstreams
(such as Slc27a2, Slc27a5, Fabp1, Fabp2 and Ppara)
and downstreams (such as bile biosynthesis, fatty acid
metabolism and lipid metabolism) of the PPAR signal-
ing pathway were downregulated (Additional file 2:
Table S2, Figs. 3 and 4a-b) in the present study.
Comparative toxicogenomics database analysis
of infected liver
In infected liver, over 800 chemical metabolism pro-
cesses could be affected by the downregulated tran-
scripts whose products are involved in xenobiotic or
drug metabolism. The chemicals include narcotics, tran-
quilizers, ethanol, antibiotics, anti-inflammatory medi-
cines, toxicants, lipids, acids, cancerogens and other
chemicals. The relationship between the chemicals and
differentially expressed genes that are involved in chem-
ical metabolisms are listed in Additional file 5: Table S5.
The Comparative Toxicogenomics Database analysis also
gave us a list of liver-related diseases that may associate
with T. gondii infection. In total, 39 liver-related diseases
were shown in Toxicogenomics Database analysis, in-
cluding carcinoma, cholestasis, liver cirrhosis, necrosis,
drugs induced liver injury, fatty liver, fibrosis, inflamma-
tion and other diseases. The relationship between differ-
entially expressed genes and liver diseases are listed in
Additional file 6: Table S6.
Table 1 Genes and primers used in Q-PCR validation
Gene Accession No. Primer name Primer sequence (5′ to 3′) Product length (bp)
Fbln5 NM_011812.4 Fbln5-F1 TAGAGCTCAAGGCTAGAAG 94
Fbln5-R1 ACTTAGCGTCTCTACTCTG
Car3 NM_007606.3 Car3-F1 CAGCCCTGGTCAGCATCT 145
Car3-R1 ATTGGCGAAGTCGGTAGG
Cyp2c69 NM_001104525.1 Cyp2c69-F1 CTGAGAAAGGCACGAAGT 232
Cyp2c69-R1 GAATGAGGTCCAACGATA
Atp6v0a4 NM_080467.3 Atp6v0a4-F1 ATTCTCAGCCTCTTCAATCA 195
Atp6v0a4-R1 CAGAAACATGCCGATAAAGT
Gbp2b NM_010259.2 Gbp2b-F AAATGGCCTCAGAAATCCAC 107
Gbp2b-R1 TTGGATAGCAGACAGGATGT
Maoa NM_173740.3 Maoa-F1 AGATTTCTAAGCCTACCTGT 136
Maoa-R1 GAGCCCTAATTTCATTCTGT
Serpina6 NM_007618.3 Serpina6-F1 ACACCACCAAAGACACTCC 193
Serpina6-R1 ATCATCAGGCTGCTCCAT
Ifng NM_008337.4 Ifng-F1 CCTGAAAGAAAGCAGTGTCT 85
Ifng-R1 TTTGTCATTCGGGTGTAGTC
Il1b NM_008361.4 Il1b-F1 ACAGTGATGAGAATGACCTG 332
Il1b-R1 GTAGTGCAGTTGTCTAATGG
Cat NM_009804.2 Cat-F1 GCAGTGATTTCACATAGGAT 131
Cat-R1 GAGAGCTGGTAATCTCTACT
β-actin NM_007393.5 β-actin-F1 GCTTCTAGGCGGACTGTTAC 100
β-actin-R1 CCATGCCAATGTTGTCTCTT
Forward (F1) and reverse (R1) primers used for quantitative PCR
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Liver inflammation, histopathological and functional analysis
The data of all liver functional test items followed a
normal distribution. Globulin (Kolmogorov-Smirnov
test P = 0.540; Independent sample t-test: t(4) = 6.881,
P < 0.0001), adenosine deaminase activity (Kolmogorov-
Smirnov test P = 0.318; Independent sample t-test: t(4) =
6.771, P = 0.015), total bile acid (Kolmogorov-Smirnov test
P = 0.661; Independent sample t-test: t(4) = 5.494, P <
0.0001), glutamic-pyruvic transaminase activity (Kolmogo-
rov-Smirnov test P = 0.627; Independent sample t-test: t(4)
=17.748, P = 0.002) and glutamic-oxaloacetic transaminase
activity (Kolmogorov-Smirnov test P = 0.81; Independ-
ent sample t-test: t(4) = 8.383, P = 0.001) were signifi-
cantly higher in infected mice serum, while albumin
(Kolmogorov-Smirnov test P = 0.24; Independent sam-
ple t-test: t(4) = -9.280, P = 0.009), alkaline phosphatase
activity (Kolmogorov-Smirnov test P = 0.633; Independ-
ent sample t-test: t(4) = -17.501, P < 0.0001) and high dens-
ity lipoprotein (Kolmogorov-Smirnov test P = 0.751;
Independent sample t-test: t(4) = -4.988, P = 0.002) were
Fig. 1 Coefficient of variation (CV) of the three replicates and validation of RNA-seq. a X-axis shows the % variation (blue bars) and left Y-axis shows the
transcript number. Right Y-axis shows the cumulative variation (red). b Comparison of the results of ten transcripts between Q-PCR and
RNA-seq. Bars indicate standard deviations
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Fig. 2 The differentially expressed genes involved in the metabolism of xenobiotics or drugs in the infected liver. The 109 differentially expressed
genes involved in xenobiotic or drug metabolism were classed into nine groups, including UDP glucuronosyltransferases, sulfotransferases,
glutathione S-transferases, cytochrome P450, flavin containing monooxygenases, aldo-ketoreductases, NAD(P)H dehydrogenases and other
metabolic enzymes. Green spot represents downregulation, red spot represents upregulation
Fig. 3 Significantly enriched pathways in T. gondii-infected liver. Eighty-four pathways were significantly enriched. Green represents downregulation,
red represents upregulation
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significantly lower in the infected group (Fig. 5a-d). As
shown in Fig. 6, mouse liver was damaged by T. gondii
infection. Inflammatory cell infiltration, hepatocellular
necrosis and liver steatosis were observed in mice of
the infected group (Fig. 6a, b). There were 43 cytokines
differentially expressed in infected liver, most of these
upregulated (Fig. 5e). No histopathological change was
observed in control liver (Fig. 6c).
Transcription factor analysis of infected liver
In the present study, 99 transcription factors, four chro-
matin remodeling factors and 28 transcription co-factors
were differentially expressed in infected livers; these can
be clustered into 31 subsets according to the their family
(Fig. 7). In Pscan analysis, the top ten transcription fac-
tors used by upregulated genes were Spi1, Erg, Ets1, Ehf,
Nfkb1, Stat2, Stat1, Klf1, Fli1 and Irf1, while the top ten
transcription factors used by downregulated genes were
Hnf4a, Hnf4g, Sp2, Sp1, Klf5, Nr2f1, Klf4, Nr2c2, Pparg
and Rxra.
Discussion
We used next-generation sequencing to analyze the glo-
bal transcriptomic change in the liver of mice infected
with T. gondii. A total of 2,758 transcripts were differen-
tially expressed in infected liver and our q-PCR valid-
ation confirmed the differentially expressed (Fig. 1b).
Infected livers showed differential gene expression in
pathways classified in the immune response (upregu-
lated) and xenobiotic metabolism, fatty acid metabolism,
energy metabolism, and bile biosynthesis and secretion
response (downregulated).
Inflammation is the backbone of immune response
which eliminates T. gondii infection via stimulating vari-
ous immune cells to secret various cytokines and che-
mokines. Even though we observed inflammatory cells
Fig. 4 Downregulation of PPAR pathway and bile acid biosynthesis and secretion pathway. a Downregulation of PPAR signaling pathway.
b Downregulation of bile acid biosynthesis and secretion pathway. Solid arrows indicate direct effect and dotted arrows indicate indirect
effect. Red and green colour for genes indicate increased and decreased expression, respectively. The pathways were modified from the
PPAR signaling pathway, the primary bile acid biosynthesis pathway and the bile secretion pathway of KEGG database. Abbreviations: BA,
bile acid; HDL, high density lipoprotein
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in pathological sections, identification of the different
cell types in haematoxylin & eosin-stained sections was
not possible. However, according to a published report
[28], it is apparent that many cells including Th1, Th17,
Treg cells, neutrophils, monocytes, macrophages, baso-
phils, immature dendritic cells (iDCs), dendritic cells
(DCs) and natural killer cells (NKs) could infiltrate to in-
fected liver for the upregulation of chemokines (such as
CXCL9, CXCL10, CXCL11, CXCL13, CXCL16, CXCL14,
CCL19, CCL2, CCL3, CCL4 and CCL5). Overall, 43 cy-
tokines were differentially expressed in infected liver,
most of them were upregulated, including IFN-γ, IL-1β
(Fig. 5e). DCs produce IL-12 after encountering T. gon-
dii and stimulate NK cells to produce IFN-γ as well as
promote the development of Th1 cells, which are im-
portant in adaptive immunity. However, over production
of IL-12 and IFN-γ can cause lethal tissue damage. Th1
cells can produce IFN-γ through activation of myeloid
differentiation primary-response protein 88 (Myd88)
pathway and neutrophils produce IFN-γ in IL-1β-
depend manner [29, 30]. Although IL-1β was upregu-
lated in present study, the extent to which neutrophil
contributes to IFN-γ production in infected liver is still
unknown. Il1rn, which functions as interleukin 1 recep-
tor antagonist and blocks IL-1β signaling transduced
into neutrophil [31], was also upregulated. The upregu-
lation of Il1rn was also observed in infected mouse
spleen [17].
IFN-γ is the most important cytokine that eliminates
intracellular T. gondii by upregulating three pathways: (i)
the immunoregulatory enzyme indoleamine 2,3-dioxy-
genase (IDO) to deplete local cellular tryptophan; (ii)
Fig. 5 Results of liver functional analysis and the differentially expressed cytokines. a-c Levels of biochemical parameters in the mice serum.
d The transcript change of adenosine deaminase (Ada), butyrylcholinesterase (Bche), glutamicpyruvic transaminase (Gpt), glutamatic-oxaloacetic
transaminase 2 (Got2) in infected liver. e The differentially expressed cytokines in infected liver. Bars indicate standard deviations; units of biochemical
parameters are shown along the X-axis. Unit abbreviations: g, gram; l, litre; U, unit; 10U, 10 units; UI, international unit; μmol, micromole; mmol,
millimole. * Independent sample t-test, P < 0.05. ** Independent sample t-test, P < 0.01. *** Independent sample t-test, P < 0.001
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inducible nitric oxide synthase (iNOS) to limit cellular
arginine; (iii) interferon inducible immunity related
GTPases (IRGs) and guanylate binding proteins (GBPs)
to destroy the parasitophorous vacuole membrane
(PVM), which is used by T. gondii to acquire nutrients,
hijack host organelles and protect the parasite from
host immune systems [29, 32]. Notably, our study re-
vealed that IFN-γ (Ifng), two iNOS (Nos2 and Nos3),
one IDO (Ido1), seven IRGs (Irgm1, Irgm2, Iigp1,
9930111J21Rik2, Tgtp1, Tgtp2 and Gm12250) and nine
GBPs (Gbp2, Gbp2b, Gbp3, Gbp4, Gbp5, Gbp6, Gbp8,
Gbp9 and Gbp10) were upregulated. For innate im-
mune pathways, toll-like receptor signaling pathway,
NK cell mediated cytotoxicity and cytosolic DNA-
sensing pathway were also upregulated (Fig. 3). The
importance of toll-like receptor signaling pathway and
NK cells for anti-T. gondii infection have been dis-
cussed in a previous review [29]. Further research is
needed to elucidate the involvement of the cytosolic
DNA-sensing pathway in T. gondii infection.
C-type lectin signaling pathway is another pathway
that links innate immune response and adaptive im-
mune response. Two recent reports showed that C-type
lectin can restrict T. gondii parasitism [33, 34]. In the
present study, ten C-type lectin molecules were differ-
entially expressed, including eight upregulated C-type
lectins (Clec12a, Clec1b, Clec4a1, Clec4a2, Clec4a3,
Clec4e, Clec4n and Clec7a) and two downregulated C-
type lectins (Clec11a and Clec3b). The function of
Clec7a which contributes to T. gondii resistance has
been discussed previously [34]. However, the functions
of other differentially expressed C-type lectins are still
unclear. Further studies should enhance our understand-
ing of the role of C-type lectins in T. gondii infection.
Inflammation helps the host to eliminate T. gondii
infection, at the same time, it can cause liver damage
and impact bile biosynthesis [35]. Our histopathological
analysis, liver functional test and transcriptomic ana-
lysis confirmed the liver inflammation and damage
associated with T. gondii infection. For example, infil-
trating inflammatory cell (Fig. 6a), necrosis of hepato-
cyte and liver steatosis (Fig. 6b) were observed in
infected liver. Additionally, serum bile acid, adenosine
deaminase and transaminase activity were upregulated
in infected mice (Fig. 5a-c). The upregulation of serum
bile acid, adenosine deaminase and transaminase activity
is a sensitive biomarker of hepatocellular injury [36, 37].
Previous report confirmed that the upregulated serum bile
acid results from the inability of hepatocyte to remove bile
acid from serum [38]. As shown in Fig. 4b, hepatocellular
bile reabsorption process was reduced by the downregula-
tion of bile transporters, such as Ephx1, Slc10a1, Slco1a4,
Slco1a1, Slco1b2, Slc22a7 and Slc22a1. In addition, hepa-
tocellular bile acid biosynthesis and secretion process was
Fig. 6 Pathological sections of mice liver. Histological section showing inflammatory cell infiltration (a), necrosis and slight steatosis in infected
liver (b) compared to control mice (c). Scale-bars: 40 µm
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also downregulated by the downregulation of Tm7sf2,
Sc5d, Cyp46a1, Cyp27a1, Cyp7a1, Cyp7b1, Cyp8b1,
Akr1d1, Slc27a5, Scarb1, serum high density lipopro-
tein (HDL), Abcc3, Aqp8, Abcg5, Abcg8, Abcb11,
Abcb1a and Abcb4.
Downregulation of bile acid biosynthesis and secretion
could result in low level of bile entering host intestine,
which favors gram-negative bacteria and induces intes-
tinal dysbacteriosis and pathology [39]. This finding is
consistent with the fact that T. gondii infection increases
intestinal gram-negative bacteria population [40]. Several
reports have confirmed that T. gondii infeciton can in-
duce mice intestinal pathological changes [40–45] and
the increasing intestinal gram-negative bacterial popula-
tion is one of the intestinal pathological inducers [40].
Biological processes in both liver and intestine are
closely connected. The presence of intestinal pathology
allows intestinal bacterial metabolic products to leak via
blood vessel to liver and function as a positive feedback
to enhance liver inflammation [46]. Our results suggest
that T. gondii infection in liver can influence host health
via inducing hepatic inflammation, decreasing bile bio-
synthesis and secretion, and ultimately could contribute
to intestinal dysbacteriosis described previously and
intestinal damage [40] which forms a cycle of hepatic in-
flammation and intestinal pathology (Fig. 8).
Bile biosynthesis and secretion is also associated with
serum alkaline phosphatase activity and the bile acid is
one inducer of alkaline phosphatase [47]. In the present
study, serum alkaline phosphatase activity was downreg-
ulated. So the downregulation of bile acid biosynthesis
and secretion could contribute to the low serum alkaline
phosphatase activity in infected mice.
In addition to bile biosynthesis and secretion, another
important function of the liver is drug or xenobiotic deg-
radation. Generally, there are three phases for drug or
xenobiotic metabolism in the liver. In phase I lipophilic
molecules are transformed into hydrophilic molecules me-
diated by cytochrome P450 and NADPH. The metabolites
of phase I are often toxic and carcinogenic. These must
be transformed into nontoxic material via phase II,
which is mediated by transferases and oxidoreductases,
such as UDP glucuronyltransferases, glutathione-S-
transferases, sulfotransferases, alcohol dehydrogenases,
aldo-ketoreductases, and flavin-containing monooxy-
genases. In the phase III, all final products of phase II
reactions are excreted into bile by export pumps. In-
flammation in the liver can contribute to decreased
Fig. 7 The differentially expressed transcription factors in infected liver. 131 transcription factors were differentially expressed and classified into
31 families. Green spot represents decreased expression and red spot indicates increased expression
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drug metabolism [48]. Downregulation of macrolide an-
tibiotics metabolisms and cyclosporin A metabolism
has been observed in T. gondii infection [49, 50]. How-
ever, it is unclear how many enzymes contribute to the
downregulation. Our study will fill the gaps.
In the present study, most differentially expressed genes
involved in xenobiotic or drug metabolisms, such as cyto-
chrome P450, NAD(P)H dehydrogenases, glucuronyl-
transferases, glutathione-S-transferases, sulfotransferases,
alcohol dehydrogenases, aldo-ketoreductases, flavin-
containing monooxygenases, and other genes involved in
xenobiotics or drug metabolic process, were downregu-
lated (Fig. 2). Understanding the xenobiotics or drug
metabolic kinetics for patients is very important, because
their alteration in liver may influence the response of
treated individuals to the prescribed medicines, e.g. over-
dosed acetaminophen usually induces acute liver failure
[51]. The results of Comparative Toxicogenomics Data-
base analysis showed that 71 out of 73 differentially
expressed enzymes involved in acetaminophen metab-
olism were downregulated in the infected liver. This
indicates that the problem of acetaminophen inducing
acute liver failure could be exacerbated in toxoplasmo-
sis patients due to the pharmacokinetic changes. In
addition, overdose of acetaminophen can induce mito-
chondrial DNA damage [52] or permeability transition
which could induce liver diseases [53].
Therefore, in order to avoid adverse drug reaction in
toxoplasmosis patients, the balance between medicinal
effect and toxic effect of the drug should be considered
in the light of any expected pharmacokinetic changes.
According to Comparative Toxicogenomics Database
analysis, a list of drugs or chemicals whose metabolism
could be affected in T. gondii infection is provided. The
details of the relationship between substrates and meta-
bolic enzyme are listed in Additional file 5: Table S5. Al-
though we did not directly test the pharmacokinetics
changes in infected mouse, mRNA can reflect the
change of its product [54], and hopefully our analysis
could provide valuable data for helping toxoplasmosis
patients to choose medicine and to avoid potential ad-
verse drug reactions.
Gene transcription is regulated by cellular transcrip-
tion factors. Studying transcription factor usage could be
helpful for uncovering the relationship between T. gondii
infection and liver functional changes. In the present
study, 99 transcription factors, four chromatin remodel-
ing factors and 28 transcription co-factors were differen-
tially expressed. Some families of transcription factors
showed common changes. For example, Forkhead, CTF/
NFI and ESR-like families were downregulated while
ETS, SAND, STAT and zf-GATA families were upregu-
lated (Fig. 7). Through comparative analysis of the top
ten usages of transcription factors between upregulated
and downregulated genes, we detected a bias character
of transcription factor usage. Top ten transcription fac-
tors used in upregulated gene expressions were Spi1,
Erg, Ets1, Ehf, Nfkb1, Stat2, Stat1, Klf1, Fli1 and Irf1,
while top ten transcription factors involved in downreg-
ulated gene expressions were Hnf4a, Hnf4g, Sp2, Sp1,
Klf5, Nr2f1, Klf4, Nr2c2, Pparg and Rxra. According to
KEGG database analysis, Pparg and Rxra are the compo-
nents of PPAR signaling pathway, which plays important
roles in regulating host bile biosynthesis, fatty acid me-
tabolism, lipid metabolism and energy metabolism. In
our study, both the upstreams and downstreams of the
PPAR signaling pathway were downregulated. Fatty acid
and lipid metabolism are both important sources of
energy. Disruption of PPAR pathway can impair host en-
ergy production [55–57]. In our study, the energy related
GO terms or pathways, such as hepatocellular ATP bio-
synthetic process, tricarboxylic acid cycle, fatty acid me-
tabolism, lipid metabolism, pyruvate biosynthetic process,
proton-transporting ATP synthase complex, mitochondrial
respiratory chain complex I and III, CoA dehydrogenase
or carboxylase activity and oxidative phosphorylation path-
way, were downregulated (Additional files 2, 3 and 4:
Tables S2, S3 and S4; Fig. 3). A severe impairment of
Fig. 8 Potential link between T. gondii infection and liver injury and intestinal pathology. Question mark indicates a potential link
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energy production in hepatocytes could result in a
series of injuries, such as liver necrosis, fatty liver and
inflammation [53]. These pathological changes are con-
sistent with the results of Comparative Toxicogenomics
Database analysis (Additional file 6: Table S6) and our
histopathological analysis (Fig. 6a, b). The PPAR path-
way also participates in host anti-inflammation process
[58]. Our results of transcription factor analysis showed
that T. gondii could contribute to host liver systemic
changes via downregulated host hepatocellular PPAR
signaling pathway.
Conclusions
Our study identified 2,758 differentially expressed
transcripts in infected liver, including 1,356 downregu-
lated transcripts and 1,402 upregulated transcripts. In-
fected liver showed upregulation of immune-related
GO terms, immune response pathways and downregu-
lation of metabolic-related GO terms and pathways.
Pharmacokinetics of more than 800 chemical (includ-
ing some prescription drugs) could be altered due to the
downregulation of enzymes involved in the xenobiotic
metabolism. Our findings also demonstrated downregula-
tion of hepatocellular fatty acid metabolism, lipid metabol-
ism, energy metabolism, bile biosynthesis and secretion.
The downregulation of bile biosynthesis and secretion
suggests a potential mechanistic pathway in mice link-
ing liver and intestinal pathologies during acute T. gon-
dii infection. Comparative analysis of transcription
factor usage between upregulated and downregulated
genes suggests that T. gondii could hijack hepatocellu-
lar PPAR signaling pathway to alter host liver biochem-
ical processes. Although the response of mice liver may
not be specific to T. gondii infection, our results pro-
vide valuable data for studying the response in the in-
fected mouse liver.
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